Target Name: NPSR1
NCBI ID: G387129
Review Report on NPSR1 Target / Biomarker Content of Review Report on NPSR1 Target / Biomarker
NPSR1
Other Name(s): NPSR1 variant 1 | Neuropeptide S receptor (isoform B) | G-protein coupled receptor PGR14 | Neuropeptide S receptor 1, transcript variant 1 | VRR1 | NPSR | vasopressin receptor-related receptor 1 | neuropeptide S receptor 1 | G protein-coupled receptor 154 | GPRA | NPSR1 variant 2 | NPSR1_HUMAN | GPR154 | Neuropeptide S receptor | ASRT2 | NPSR1 variant 3 | Neuropeptide S receptor 1, transcript variant 3 | PGR14 | G-protein coupled receptor for asthma susceptibility | Neuropeptide S receptor 1, transcript variant 2 | Vasopressin receptor-related receptor 1 | G-protein coupled receptor 154 | Neuropeptide S receptor (isoform A)

NPSR1: A Potential Drug Target and Biomarker for Diseases

NPSR1 (NPSR1 variant 1) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. NPSR1 is a non-coding RNA molecule that is expressed in various tissues and cells in the body.

The NPSR1 gene has been shown to play a role in the regulation of gene expression and has been linked to the development and progression of various diseases. For example, studies have shown that NPSR1 is involved in the regulation of cell adhesion, a process that is critical for tissue repair and regeneration. NPSR1 has also been shown to be involved in the regulation of cell lifespan, as well as in the regulation of cellular processes such as cell signaling and cell death.

In addition to its role in gene regulation, NPSR1 has also been shown to play a role in the development of certain diseases. For example, studies have shown that individuals with certain genetic variations in the NPSR1 gene are at increased risk for the development of certain neurological disorders, such as Alzheimer's disease and Parkinson's disease.

Given the potential role of NPSR1 in the development and progression of various diseases, NPSR1 has also been identified as a potential drug target. Researchers have been exploring the use of drugs that can modulate NPSR1 expression to treat diseases that are characterized by the over-expression or under-expression of NPSR1. For example, studies have shown that inhibiting NPSR1 expression can be an effective way to treat certain neurological disorders, such as Alzheimer's disease.

In addition to its potential as a drug target, NPSR1 has also been shown to be a potential biomarker for certain diseases. For example, studies have shown that the expression of NPSR1 is significantly altered in the brains of individuals with certain psychiatric disorders, such as depression and anxiety. This suggests that NPSR1 may be a useful biomarker for the diagnosis and treatment of certain psychiatric disorders.

Overall, NPSR1 is a gene that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of NPSR1 in disease development and to develop effective treatments based on NPSR1 inhibition or modulation.

Protein Name: Neuropeptide S Receptor 1

Functions: G-protein coupled receptor for neuropeptide S (NPS) (PubMed:16790440). Promotes mobilization of intracellular Ca(2+) stores (PubMed:16790440). Inhibits cell growth in response to NPS binding (PubMed:15947423). Involved in pathogenesis of asthma and other IgE-mediated diseases

The "NPSR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPSR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF